Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

711 results about "High cell" patented technology

Product quality enhancement in mammalian cell culture processes for protein production

The present invention describes methods and processes for the production of proteins, particularly glycoproteins, by animal cell or mammalian cell culture, illustratively, but not limited to, fed-batch cell cultures. The methods comprise feeding the cells with D-galactose, preferably with feed medium containing D-galactose, preferably daily, to sustain a sialylation effective level of D-galactose in the culture for its duration, thus increasing sialylation of the produced proteins. The methods can also comprise at least two temperature shifts performed during the culturing period, in which the temperature is lower at the end of the culturing period than at the time of initial cell culture. The cell culture processes of the invention involving two or more temperature shifts sustain a high cell viability, and can allow for an extended protein production phase. The methods can also comprise the delayed addition of polyanionic compound at a time after innoculation. Supplementation of the cultures with D-galactose, preferably in a feed medium, to sustain galactose at sialylation effective levels in the cultures until the end of a culture run reverses a decline in sialylation that accompanies culture scale up, and is advantageous for large scale culturing processes.
Owner:BRISTOL MYERS SQUIBB CO

Product quality enhancement in mammalian cell culture processes for protein production

The present invention describes methods and processes for the production of proteins, particularly glycoproteins, by animal cell or mammalian cell culture, illustratively, but not limited to, fed-batch cell cultures. The methods comprise feeding the cells with D-galactose, preferably with feed medium containing D-galactose, preferably daily, to sustain a sialylation effective level of D-galactose in the culture for its duration, thus increasing sialylation of the produced proteins. The methods can also comprise at least two temperature shifts performed during the culturing period, in which the temperature is lower at the end of the culturing period than at the time of initial cell culture. The cell culture processes of the invention involving two or more temperature shifts sustain a high cell viability, and can allow for an extended protein production phase. The methods can also comprise the delayed addition of polyanionic compound at a time after innoculation. Supplementation of the cultures with D-galactose, preferably in a feed medium, to sustain galactose at sialylation effective levels in the cultures until the end of a culture run reverses a decline in sialylation that accompanies culture scale up, and is advantageous for large scale culturing processes.
Owner:BRISTOL MYERS SQUIBB CO

Tissue-like organization of cells and macroscopic tissue-like constructs, generated by macromass culture of cells, and the method of macromass culture

Three-dimensional tissue-like organization of cells by high cell-seeding-density culture termed as macromass culture is described. By macromass culture, cells can be made to organize themselves into a tissue-like form without the aid of a scaffold and three-dimensional macroscopic tissue-like constructs can be made wholly from cells. Tissue-like organization and macroscopic tissue-like constructs can be generated from fibroblastic cells of mesenchymal origin (at least), which can be either differentiated cells or multipotent adult stem cells. In this work, tissue-like organization and macroscopic tissue-like constructs have been generated from dermal fibroblasts, adipose stromal cells-derived osteogenic cells, chondrocytes, and from osteoblasts. The factor causing macroscopic tissue formation is large scale culture at high cell seeding density per unit area or three-dimensional space, that is, macromass culture done on a large scale. No scaffold or extraneous matrix is used for tissue generation, the tissues are of completely cellular origin. No other agents (except high cell-seeding-density) that aid in tissue formation such as tissue-inducing chemicals, tissue-inducing growth factors, substratum with special properties, rotational culture, etc, are employed for tissue formation. These tissue-like masses have the potential for use as tissue replacements in the human body. Tissue-like organization by high cell-seeding-density macromass culture can also be generated at the microscopic level.
Owner:RELIANCE LIFE SCI PVT

Front gate line electrode silver conductor slurry for environment friendly silicon solar cell

The invention relates to a formula of an environment-friendly Ag conductor slurry for a silicon solar cell front gate line electrode and a processing method thereof. The component and the content (weight percentage) of the Ag slurry are: a metal Ag powder 60-80, a lead-less glasses adhesive 1-10, an Ohm contact additive agent 0. 05-10, and organic resin 2-15and a slurry modifying agent 1-8 The production method of the environment-friendly Ag conductor slurry comprises a preparation of the lead-less glass adhesive, a formula of the Ag slurry and a processing process of the slurry. The developing Ag slurry implements the slurry lead-free by using a Ba-Zn-B glass material and the lead content of the slurry is less than 100 ppm, while the content of other harmful substances such as Hg and Cd or the like is all conformed to the environment protection demand. A good Ohm contact is formed on the silicon surface of the Ag line and the cell by adding the Ohm contact forming agent in the slurry. The Ag slurry has strong adhesive force, superior weldability, good Ohm contact and high cell conversion efficiency after a continuous tunnel furnace fast heat treatment when the Ag slurry is used in the silicon solar cell front gate line electrode.
Owner:河北晶乐光电科技有限公司

Aptamer-based microfluidic chip capable of capturing cancer cells and preparation thereof as well as separation method of cancer cells

The invention discloses an aptamer-based microfluidic chip capable of capturing cancer cells, which is formed by reversibly sealing an upper-layer polymer chip and a lower-layer slide carrier, wherein a cell capturing channel is arranged between the upper-layer polymer chip and the lower-layer slide carrier; the bottom surface of the channel is rough; and avidin is fixed on the bottom surface. The preparation of the microfluidic chip comprises the steps of making a chip die by photoetching, and casting to obtain a polymer chip; processing the slide carrier with hydrofluoric acid and bonding with the polymer chip; and fixing avidin in the cell capturing channel to obtain a microfluidic chip. The microfluidic chip disclosed by the invention can be used for separating cancer cells; and the separation comprises the steps of adding biotin-modified aptamer into a sample, and incubating; and leading the mixed solution after the incubation into the microfluidic chip, wherein the target cancer cells in the mixed solution are combined with the avidin through the biotin to realize separation of the target cancer cells. The microfluidic chip disclosed by the invention has the advantages of high cell capturing efficiency, convenience in operation, strong generality, low cost and the like.
Owner:HUNAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products